Elligo-Syneos Synergy To Revolutionize Clinical Trial Pipeline Management

In a groundbreaking collaboration, Elligo Health Research® and Syneos Health are set to reshape the landscape of clinical trials through the expansion of Elligo’s Study Marketplace platform. This partnership promises to unlock new frontiers in clinical research, providing an unprecedented avenue for sites, sponsors, and patients to engage seamlessly in the clinical trial process. Let’s delve into the intricate details of this innovative platform and explore how it stands poised to revolutionize clinical trial pipeline management.

The Genesis of IntElligo® Study Marketplace

Launched in November 2022, IntElligo® Study Marketplace is an online platform designed to bridge the gap between clinical trial sponsors, clinical research organizations (CROs), and sites. At its core, the platform aims to enhance transparency and efficiency during the sales and site selection process. With a user-friendly interface, Study Marketplace serves as a beacon for over 500 subscribing sites, offering them a curated list of studies tailored to their interests, capabilities, and patient populations.

This platform signifies a departure from traditional approaches, eliminating the arduous task of scouring through countless emails for study opportunities. Instead, it provides a centralized hub for sponsors to list their studies, allowing sites to easily review, apply, and monitor progress—all within a singular, intuitive portal.

Navigating the Study Marketplace

Study Marketplace goes beyond mere convenience; it transforms the way sites interact with study opportunities. A quick two-minute assessment is all it takes for sites to evaluate whether a study aligns with their profile and goals. The platform’s dynamic features include curated recommendations, short synopses of essential details, and a streamlined application process, empowering sites to make informed decisions efficiently.

The “My Studies” page becomes the nerve center for site operations, offering tools to check feasibility, manage tasks, and ensure the seamless progression of study applications. This holistic approach ensures that sites are well-informed and equipped at every stage of the sales cycle.

Up-to-Date Study Documents and Easy Collaboration

One of the hallmark features of IntElligo® Study Marketplace is its commitment to keeping study information up-to-date and easily accessible. Detailed study documents, including current protocol synopses, feasibility questionnaires, and pre-study visit preparations, are consolidated within the platform. This eliminates the need for sites to rummage through their inboxes for crucial details.

Moreover, with an unlimited number of users per site, the Study Marketplace fosters collaboration among team members. This collaborative environment ensures that sites stay organized and can efficiently work together to streamline processes.

A Transformative Clinical Partnership

Elligo Health Research® CEO & Co-Founder John Potthoff, Ph.D., expressed gratitude for the partnership with Syneos Health, dating back to 2018. By incorporating Syneos Health trials into the Study Marketplace, the process is set to transition from a manual ordeal to a seamless digital experience. This transition allows sites to review and apply for Syneos Health studies effortlessly, freeing up more time for critical aspects of trial execution and patient care.

Syneos Health President, Terttu Haring, M.D., highlighted the laser focus on addressing the needs of sites, sponsors, and patients. The move to Study Marketplace is seen as a strategic shift, recognizing the value of a platform that efficiently allows sites to view study opportunities and expedite the clinical trial process.

As this transformative partnership unfolds, the synergy between Elligo Health Research® and Syneos Health promises not only to optimize customer success but also to accelerate the development of life-changing therapies on a global scale. The IntElligo® Study Marketplace stands as a testament to the power of innovation in reshaping the future landscape of clinical trials.

About Elligo Health Research®

In the realm of clinical research, Elligo Health Research® stands as a trailblazing integrated research organization with a singular mission—to facilitate easy access to research participation for everyone while expediting the pace of clinical trials. Founded in 2016 by Dr. John Potthoff and Chad Moore, Elligo emerged as a response to the frustrations observed in the clinical research landscape. Witnessing patients struggling to access trials, physicians grappling with inefficiencies in trial management, and sponsors facing challenges in timely trial completion, the co-founders resolved to bring about transformative change.

The foundational ethos of Elligo is rooted in the belief that the power of healthcare data can profoundly influence and guide clinical research. Rather than advocating for disruption, Elligo emphasizes the importance of compliance and change through adoption. This philosophy underlines their commitment to driving research efficiency through innovation while preserving the crucial connection between physicians and their patients.

The year 2020 marked a significant expansion for Elligo with the strategic acquisitions of Root Health and ClinEdge. This expansion not only fortified their position but also propelled them into international territories, as they set their sights on simplifying the clinical research process globally.

Elligo’s revolutionary approach to clinical research is underpinned by several key pillars. The organization provides early, direct access to a network of diverse, pre-vetted patients using HIPAA-compliant identified electronic health record (EHR) data. The IntElligo® Research Stack technology ensures data integrity throughout the research lifecycle, from patient identification to study closure. Through Research Partner Services, Elligo empowers healthcare practices and research sites to seamlessly participate in clinical trials, positioning them as “Research Ready.”

Beyond the technical aspects, Elligo places immense value on preserving the integrity of the trusted patient-physician relationship. The organization actively builds local healthcare communities, leveraging EHRs to bring clinical research closer to patients as a form of care.

The innovation propagated by Elligo is not solely a means to accelerate the development of pharmaceutical, biotechnological, and medical device products; it is a commitment to positively impact lives globally. The team at Elligo is unwaveringly dedicated to this cause, driven by a genuine care for the individuals working to create life-saving solutions and the families who depend on them. By providing support to clients developing new therapies and facilitating greater access to clinical trial participation, Elligo believes it is contributing to making the world a healthier, happier place. This deep-seated commitment propels Elligo to approach its work with meticulous attention, ensuring that every action aligns with the goal of supporting those navigating through challenging times.

More about Elligo Health Research® from their Official Website.

About Syneos Health

Syneos Health stands as a preeminent fully integrated biopharmaceutical solutions organization meticulously crafted to expedite the triumph of its clientele. This innovative entity adeptly translates distinctive clinical, medical affairs, and commercial insights into tangible outcomes, strategically navigating the complexities of contemporary market landscapes.

The backbone of Syneos Health lies in its assembly of a highly skilled and diverse team of professionals spanning across more than 110 countries. This global collective boasts an intimate comprehension of both patient and physician behaviors, coupled with a nuanced understanding of the ever-evolving market dynamics. Collaboratively, these experts leverage shared insights, cutting-edge technologies, and advanced business methodologies to accelerate the delivery of crucial therapies to patients in need.

Embedded within the core ethos of Syneos Health is an unwavering commitment to fostering a culture that is not only diverse and equitable but also deeply inclusive. This commitment extends beyond the organization’s boundaries to encompass care for colleagues, customers, patients, communities, and the environment at large.

Syneos Health prides itself on being more than a mere service provider; it is a Partner with Purpose. When entering into partnerships, the organization seamlessly aligns its goals with those of its clients, ensuring a responsive and tailored approach. The collaboration entails active listening and the strategic deployment of specialized experts precisely when and where needed, instilling confidence at every juncture of the client’s journey.

Central to Syneos Health’s operational model is the meticulous crafting of individual project teams. This Therapeutic Depth is not just a slogan; it represents a commitment to the success of clients. These teams are meticulously composed of specialized experts uniquely suited to meet the distinctive needs of each project, thereby delivering profound insights to expedite the development and delivery of therapeutic solutions.

At the heart of Syneos Health’s offering is a suite of Insights-Based Solutions that span the entire clinical-to-commercial spectrum. These solutions, underpinned by AI- and tech-enabled insights, are strategically designed to enhance performance, mitigate risks, and expedite the global delivery of much-needed therapies.

Among the standout offerings is the Medical Affairs suite, which provides strategic insight, scientific expertise, organizational excellence, and purposeful engagement. This suite supports evidence-based strategies across the entire clinical to commercial continuum, ensuring a holistic and informed approach.

The modern customer engagement capability, Kinetic™, takes center stage, deploying advanced targeting, analytics, and cutting-edge technologies. Kinetic makes fully integrated omnichannel solutions accessible to healthcare organizations, enabling them to navigate the intricacies of contemporary customer engagement.

Syneos One® emerges as a fully integrated, insights-driven asset development methodology. This unique approach offers a seamless fusion of asset strategy and execution, aiming to maximize value from early concept through commercialization.

Syneos Health stands as a beacon in the biopharmaceutical landscape, embodying a commitment to excellence, innovation, and purpose-driven collaboration, all in service of accelerating the delivery of transformative therapies to patients worldwide.

Learn more about Syneos Health via this link.

Engr. Dex Marco Tiu Guibelondo, B.Sc. Pharm, R.Ph., B.Sc. CpE

Editor-in-Chief, PharmaFEATURES